R&D expenditures by field of science and GDP: Which causes which in Canada?

被引:1
作者
Doyar, B. Veli [1 ]
机构
[1] Suleyman Demirel Univ, Inst Social Sci, Isparta, Turkey
来源
ECONOMICS AND BUSINESS LETTERS | 2019年 / 8卷 / 01期
关键词
R&D; GDP; economic growth; causality; Canada; OPTIMAL LAG ORDER; TIME-SERIES; PRODUCTIVITY GROWTH; ECONOMIC-GROWTH; MODELS; INNOVATION; CAUSALITY; INFERENCE;
D O I
10.17811/ebl.8.1.2019.31-40
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper attempts to reveal the relationship between GDP per capita and R&D expenditure per capita, R&D expenditure per capita on natural sciences and engineering, and R&D expenditure per capita on social sciences and humanities for Canada. Based on data from 1981 to 2014, bootstrap causality test proposed by Hacker and Hatemi-J (2006) show that there is a unidirectional causality from GDP per capita to R&D expenditure per capita, and a unidirectional causality from GDP per capita to R&D expenditure per capita on natural sciences and engineering. However, no causal relationship is observed between R&D expenditure per capita on social sciences and humanities and GDP per capita. These results may point an indirect relationship between the variables or the validity of R&D paradox and the European paradox for Canada.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [41] Investigation of the Effect of R&D, Education and Health Expenditures on Economic Growth by Panel Data Analysis Method
    Gokkaya, Durmus
    Senol, Osman
    Cirakli, Umit
    SOSYOEKONOMI, 2021, 29 (50) : 95 - 108
  • [42] Science Is Golden: Academic R&D and University Patents
    Tom Coupé
    The Journal of Technology Transfer, 2003, 28 (1) : 31 - 46
  • [43] Expenditure on R&D, GDP and its impact on the Ecological footprint in South America
    Genesis-Carolina, Torres-Gonzalez
    Viviana, Torres-Diaz
    Wilman-Santiago, Ochoa-Moreno
    PROCEEDINGS OF 2021 16TH IBERIAN CONFERENCE ON INFORMATION SYSTEMS AND TECHNOLOGIES (CISTI'2021), 2021,
  • [44] Capitalization vs. expensing and the behavior of R&D expenditures
    Oswald, Dennis
    Simpson, Ana
    Zarowin, Paul
    REVIEW OF ACCOUNTING STUDIES, 2022, 27 (04) : 1199 - 1232
  • [45] The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
    Jörg C. Mahlich
    Thomas Roediger-Schluga
    Review of Industrial Organization, 2006, 28 : 145 - 164
  • [46] The Role of R&D Expenditures in People's Innovative Potential
    Jurickova, Eva
    PROCEEDINGS OF THE 9TH EUROPEAN CONFERENCE ON INNOVATION AND ENTREPRENEURSHIP (ECIE 2014), 2014, : 260 - 267
  • [47] The determinants of pharmaceutical R&D expenditures: Evidence from Japan
    Mahlich, JC
    Roediger-Schluga, T
    REVIEW OF INDUSTRIAL ORGANIZATION, 2006, 28 (02) : 145 - 164
  • [48] Detecting which firm-specific characteristics impact market-oriented R&D
    Hsu, Kuang-Chung
    Weng, Yungho
    EMPIRICAL ECONOMICS, 2018, 55 (04) : 1695 - 1715
  • [49] The decline of science in corporate R&D
    Arora, Ashish
    Belenzon, Sharon
    Patacconi, Andrea
    STRATEGIC MANAGEMENT JOURNAL, 2018, 39 (01) : 3 - 32
  • [50] Characteristics of R&D expenditures in Japan's pharmaceutical industry
    Nivoix, Sophie
    Nguyen, Pascal
    ASIA PACIFIC BUSINESS REVIEW, 2012, 18 (02) : 225 - 240